Double-blind, double-dummy, randomized, parallel group comparison of the efficacy and safety of fluticasone proprionate aqueous nasal spray vs encapsulated loratadine tablets vs a combination of fluticasone proprionate and loratidine vs placebo for two weeks in subjects with seasonal allergic rh ...

Bowers B, Cox F, Howland W, Cook C, Westlund R, Rogenes P. Superior impact of intranasal fluticasone versus loratadine on work, home and leisure activities affected by SAR. J Allergy Clin Immunol 1997;99 (No. 1, Part 2):S439 (abstract)

Cook CK, Rickard KA, Westlund R. Onset of action of fluticasone propionate aqueous nasal spray (FP). J Allergy Clin Immunol 1999;103 (No. 1 Part 2):S114 (abstract)

Cook CK. The efficacy and safety of fluticasone propionate (FP) aqueous nasal spray and loratadine (LOR), alone and in combination, in the treatment of seasonal allergic rhinitis (SAR). J Allergy Clin Immunol 1997;99(No. 1, Part 2):S439

Cox FM, Bowers BW, Ratner PH, Cook CK, Westlund R, Rogenes PR. Patient-rated overall treatment satisfaction and effectiveness for fluticasone propionate aqueous nasal spray (FP) and loratadine (LOR), alone and in combination. Ann of Allergy, Asthma, and Immunol 1997;78(1): 127 (abstract)

DeWester J, Philpot E, Westlund RE, Cook CK, Rickard KA. The efficacy of intranasal Fluticasone Propionate in the relief of ocular symptoms associated with seasonal allergic rhinitis. Allergy and Asthma Proc 2003;24(5):331-337.

Goodwin B, Bowers B, Hampel F, Cook C, Westlund R, Cox F. Superior improvement in disease- specific quality of life for SAR patients receiving intranasal fluticasone versus loratadine tablets. J Allergy Clin Immunol 1997;99(No. 1, Part 2):S270 (abstract)

Howard K, Bowers B, Cook CK, Westlund R. Evaluation of patient and cost-effectiveness outcomes of intranasal fluticasone versus loratadine tablets versus their use in combination. J Allergy Clin Immunol 2000, 105(1):S212-213 (abstract)

Howard KB, Bowers BW, Cook CK, Westlund R, Rickard K. Intranasal Fluticasone, Loratadine Tablets, and Their Use in Combination: Evaluation of Economic and Humanistic Outcomes. Drug Benefit Trends 2001;13(10):45-52

Meltzer EO, Rickard KA, Westlund RE, Cook CK. Onset of the therapeutic effect of fluticasone propionate aqueous nasal spray. Ann of Allergy, Asthma, and Immunology 2001;86(3):286-291

Philpot E, Toler T, Rickard K. The enhancement of effect by an intranasal placebo spray on the efficacy of an oral allergy tablet comparator. J of the World Allergy Org Abstracts of the WAO Congress-XVIII ICACI Sept 2003(Suppl 1) (abstract) Ratner PH, van Bavel JH, Martin BG, Hampel FC, Howland WC, Rogenes PR, Westlund R,

Ratner PH, van Bavel JH, Martin BG, Hampel FC, Howland WC, Rogenes PR, Westlund RE, Bowers BW, Cook CK. A comparison of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, for the treatment of seasonal allergic rhinitis. J Fam Pract 1998;47118-125

Westlund RE, Cook CK, Philpot E, Sanjar K. Fluticasone Propionate Aqueous Nasal Spray 200 MG Once Daily Provides Relief of the Ocular Symptoms Associated with Seasonal Allergic Rhinitis. J Allergy Clin Immunol, 2001;107(2):S158 (abstract)

van Bavel JH, Ratner PH, Nayak AS, Shulan D, Reed KD, Rogenes PR, Cook CK. Ocular efficacy and clinician overall evaluation of intranasal fluticasone propionate (FP) versus loratadine (LOR) in seasonal allergic rhinitis (SAR). Ann of Allergy, Asthma, and Immunol 1997;78(1):128